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ABSTRACT: We report on a simple carbohydrate amphiphile 
able to self-assemble into nanofibers upon enzymatic 
dephosphorylation. The self-assembly can be triggered by alkaline 
phosphatase (ALP) in solution or in situ by the ALP produced by 
osteosarcoma cell line, SaOs2. In the latter case, assembly and 
localized gelation occurs mainly on the cell surface. The gelation 
of the pericellular environment induces a reduction of the SaOs2 
metabolic activity at an initial stage  h) that results in cell 
death at longer exposure periods  h). We show that this effect 
depends on the phosphatase concentration and thus, it is cell-
selective with prechondrocytes ATDC5 (that express ~15-20 
times lower ALP activity compared to SaOs2) not being affected 
DWFRQFHQWUDWLRQVP0. These results demonstrate that simple 
carbohydrate derivatives can be used in an anti-osteosarcoma 
strategy with limited impact on the surrounding healthy 
cells/tissues. 
Molecular self-assembly1,2 of peptide amphiphiles, short pep-
tides appended with aromatic3 or aliphatic moieties4, has been a 
hot topic in the biomedical field for the last two decades.5,6 De-
signed SHSWLGH DPSKLSKLOHV FDQ EH XVHG LQ WKH µERWWRP-up ap-
SURDFK¶WRFUHDWHVWUXFWXUHVWKDWUHVHPEOHWKHH[WUDFHOOXODUPDWUL[
(ECM) at both structural and functional levels but are much sim-
pler in composition.7-10 In addition to peptides, other self-
assembling amphiphilic molecules, including carbohydrate and 
nucleotide moieties have emerged: for example, carbohydrate 
derivatives or mixed nucleobase/amino acid/carbohydrate conju-
gates self-assemble into nanofibres and gel under specific condi-
tions (e.g. presence of certain cations, manipulation of tempera-
ture, pH, etc.).11,12 Because the self-assembly process is orches-
trated by different types of intermolecular interactions (e.g. elec-
trostatic, aromatic stacking, hydrophobic effects, hydrogen bond-
ing),13 subtle changes in the chemical structure of the amphiphile 
can affect the assembly structure and process. 
One approach to control and direct molecular self-assembly us-
es the selective catalytic activity of enzymes. Typically, enzymes 
remove steric or electrostatic blocking groups from non-
assembling amphiphile precursors and generate building blocks at 
the site of catalysis, in a process known as enzymatically-
triggered or biocatalytic self-assembly.14-16 Such systems have 
been studied for several years because of their selectivity, ability 
to trigger the assembly under physiological conditions and local-
ized action.17,18 Usually, the procedure involves recombinant en-
zymes in vitro by direct addition to the precursor solution,15,19 
with recent examples of in situ biocatalytic self-assembly that use 
enzymes present in the intracellular/pericellular 
environment.14,15,18,20-24 Phosphatases have attracted attention 
because of the abundance of phosphorylation and 
dephosphorylation reactions that take place in vivo. Especially 
alkaline phosphatase (ALP) is widely used as a diagnostic and 
prognostic marker in different pathologies.25 ALP is present in 
highly mineralized tissues and is usually expressed on the base-
ment membrane of osteoblasts.26 It is overexpressed in some oste-
osarcomas26,27 making it a valid target for localized anti-cancer 
therapies. Recently, Xu et al18 reported that enzymatic formation 
of nanofibers of self-assembled aromatic tripeptide amphiphiles in 
the pericellular space of cancer cells leads to selective inhibition 
of the cellular metabolic activity, which depends on the concen-
tration of phosphatases in the biological medium. 
Herein, we present an aromatic carbohydrate amphiphile, 
namely, N-(fluorenylmethoxycarbonyl)±glucosamine±6-
phosphate (1), as alternative substrate in this approach. Carbohy-
drates are the most abundant biomolecules and represent one of 
the four building elements of life.28,29 In particular, glucose is the 
main player in the carbohydrate metabolism because it can be 
converted into all other monosaccharides needed for the glycan 
biosynthesis. Once internalized by the cell, glucose is activated to 
the nucleotide glucose-6-phosphate (importantly not permeable to 
cell membrane) and transported to the Golgi where cell surface 
and ECM glycans are assembled.28 The generated glycans are 
involved in a plethora of biological events through specific path-
ways but also by providing mechanical cues to the cells: because 
carbohydrates are rich in hydroxyl groups they generate highly 
hydrated gels. The physiological importance of this ability of 
carbohydrates is highlighted in different tissues and organs, e.g. 
cartilage tissue is abundant in glycosaminoglycans and as a result 
70 to 85% of the weight of the whole tissue is water.30 We there-
fore hypothesize that carbohydrate amphiphiles open up com-
pletely new possibilities as therapeutic platforms complementing 
the more established peptide-based systems, due to their rich 
chemistry, gelation ability and roles in biological recognition. The 
introduction of a carbohydrate moiety will result in the formation 
of supramolecular hydrogels that share some of the glycan proper-
ties, but are much simpler. 
We report on the use of 1 as a selective ALP substrate for oste-
osarcoma cells (SaOs2). We provide data about the specificity of 
 this system by comparative tests using cells with a lower ALP 
expression profile, namely pre-chondrocytes (ATDC5). Our re-
sults demonstrate that the system can be used in an anti-
osteosarcoma strategy, with limited impact on the surrounding 
healthy cells/tissues as illustrated in Scheme 1. 
We synthesized 1 in one step starting from the hydrochloride 
salt of glucosamine-6-phosphate and using selective reaction of 
the amino group. The product was purified by HPLC and charac-
terized by different techniques (Figure S1-S5). 
 
Scheme 1. Illustration of enzymatic transformation of 1 to 
2 upon enzymatic activity of phosphatases (e.g. ALP), (A) 
chemical structures and (B) in situ biocatalytic self-
assembly. 
Self-assembly and gelation of the precursor 1 and the 
dephosphorylated analogue (i.e. 2) were evaluated using three 
different concentrations of 1 (i.e. 10, 15 and 20 mM) and different 
ALP concentrations (i.e. 25, 50 and 75 U£) in PBS at pH 7.4 (Fig-
ure 1). Concentrations of 1 were chosen to be >5 mM, the critical 
gelation concentration of 2.11 Before ALP addition, a transparent 
solution was observed which was transformed to a transparent gel 
phase upon ALP addition (Figure 1C inserts). Gelation time var-
ied from 1 h to 5 h depending on precursor and enzyme concen-
trations; gels formed faster when higher precursor and enzyme 
concentrations were used (gels tested by inverted vial method). 
 
Figure 1. Effect of the concentration of ALP and 1 on the (A) 
mechanical properties (rheology) of the formed hydrogels; (B) 
supramolecular arrangement of fluorenyl groups observed by 
monitoring fluorescence intensity of fluorenyl main peak at 320 
nm, and C) enzymatic transformation of 1 (clear solution of spher-
ical aggregates) to 2 (gel of nanofibrous networks) observed by 
TEM. 
HPLC was used to assess the ability of ALP to dephosphorylate 
1 and to study the dephosphorylation rate during 24 h (Figure S6). 
The conversion rate could be controlled by the enzyme concentra-
tion: faster conversion was observed when higher enzyme concen-
tration was used. Similar behavior was previously reported for 
phosphorylated Fmoc-dipeptide systems.14,31 
In biocatalytic self-assembly, enzyme kinetics (i.e., the rate of 
production of self-assembly building blocks) dictate gelation 
properties, such as supramolecular arrangement and the subse-
quent gel stiffness.32 Therefore, the mechanical properties of the 
formed hydrogels were evaluated by rheology after 24 h of ALP 
addition (Figure 1A and S7). As expected, higher ALP concentra-
tions led to formation of stiffer gels. These observations were 
directly correlated with fluorescence emission intensities of 
fluorenyl main peak at 320 nm (Figure 1B and S8). A clear trend 
was observed, as 1 and/or ALP concentrations increase, the peak 
at 320 nm quenches, which suggest more efficient supramolecular 
stacking within the gel fibers. The morphology of the generated 
assemblies, involving a supramolecular transformation from 
spherical aggregates for 1 to nanofibers of 2 was further charac-
terized by transmission electron microscopy (TEM) (Figure 1C 
and S9). We observed nanofibrous structures whose network den-
sity and resulting gel stiffness can be controlled by either 1 or 
ALP concentrations. 
The capacity of the recombinant ALP to induce self-assembly 
and the previous publications18,33 by Xu¶VJURXS motivated us to 
investigate this process in situ, in the presence of osteosarcoma 
cell line (SaOs2) known to overexpress ALP.26 The experiments 
were carried out both in cell suspension (i.e. non-adherent cells) 
and on cell monolayers in the presence of different concentrations 
of 1 (0-20 mM). Macroscopic gelation was visible after 2 days of 
culture when a cell suspension was used. Self-sustained macro-
scopic gels were observed at longer culture period, i.e. after 4 
days of culture (Figure S10A). Gels were formed from solutions 
of 1 with concentration of 10, 15 and 20 mM, although, only the 
gels obtained from the most concentrated solution were easy to 
further manipulate (Figure 2A). 
 
Figure 2. Self-assembly and gelation of 1 in SaOs2 suspension: 
(A) formation of gel is observed after 4 days of culture in the 
presence of 20 mM of 1, (B) SEM images reveal nucleating clus-
ters (white arrows) with (C-D) nanofibers growing in a concentric 
 manner and joining with each other, scale bar = 2 ȝm. (E) 
Biocatalytic in situ conversion of 1 to 2 executed by the SaOs2 
ALP as a function of time and initial concentration of 1. (F) ALP 
activity after 1 day of SaOs2 culture as a function of the initial 
concentration of 1. 
The gels produced with 20 mM of 1 during 4 days of cell cul-
ture were collected, dehydrated and analyzed by SEM. The imag-
es unveiled nano-fibrillar structures organized around nucleating 
clusters34 (Figure 2B). The density of the nanofibers increased 
within the clusters (Figure 2C,D), they grew and ultimately joined 
with the neighboring clusters (Figure S10B). We note that the 
morphologies of the fibers formed differ depending on the exper-
imental conditions used in the absence (Figure 1C) and presence 
of the cells (Figures 2B-D). Interestingly, the quantification of the 
1 to 2 conversion (Figure 2E) revealed a stable ~7 mM concentra-
tion of 2 in the medium after 1 day of culture, independently of 
the added quantity of 1. This observation is consistent with the 
relatively stable ALP activity at all the culture conditions, as con-
firmed by ALP quantification (Figure 2F). These results con-
firmed that the ALP produced by SaOs2 is able to convert 1 into 
the nano-fibril-forming 2. 
As expected, the SaOs2 metabolic activity was drastically af-
fected by the dephosphorylation of 1 and/or gelation of 2: we 
measured a metabolic activity below 10% for all the tested con-
centrations. Therefore, we designed a different experimental setup 
aiming to gain insights on the influence of self-assembly and gela-
tion on the cellular behavior. In these experiments, we used a cell 
monolayer that allows observation of changes in phenotype and 
cytoskeletal organization. We tested a lower range of concentra-
WLRQV mM for shorter times of cell culture (1 h and 7 h). More-
over, we assayed a second cell line at the same conditions to con-
firm if the ongoing processes are cell-specific. We have selected 
the chondrogenic cell line ATDC5 because of two main reasons: 
(i) ATDC5 present a significantly lower ALP activity when com-
pared to the SaOs2 cells and (ii) the two cell lines, SaOs2 and 
ATDC5, are usually used as in vitro models of two neighboring 
tissues, bone and cartilage, making the combined evaluation of 
both cell types highly relevant. 
 
Figure 3. Metabolic activity of SaOs2 and ATDC5 monolayer 
cultures in the presence of different concentrations of 1 (control ± 
0 mM, 0.5 mM and 1 mM), without (- I) and with (+ I) phospha-
tase inhibitor. Values refer to (A) 1 h and (B) 7 h of cell culture. 
(C) Activity of the membrane bound and extracellular ALP in the 
SaOs2 and ATDC5 cell cultures as a function of the concentration 
of 1. Quantification at 7 h of cell culture. 
The metabolic activity of ATDC5 (Figure 3A) was not affected 
by the presence of 1. In contrast, the metabolic activity of SaOs2 
cells reduced drastically at all tested concentrations of 1. This 
tendency is even more pronounced at longer culture times (Figure 
3B). In order to evaluate if this effect is a direct consequence of 
the higher ALP expression by the SaOs2 cells, we performed the 
experiment in the presence of Pierce phosphatase inhibitor. The 
addition of inhibitor resulted in very similar behavior of SaOs2 
and ATDC5 after 1 h of culture, i.e. no significant reduction of the 
metabolic activity was observed. After 7 h of culture, the differ-
ence between SaOs2 cultured with and without inhibitor (Figure 
3B) provides clear evidence of a direct relationship between the 
ALP activity and the cytotoxicity of 1. 
ALP can be expressed differently within biological systems: 
soluble, insoluble, membrane-bound, and extracellular ALP.35 
While the activity of the membrane bound ALP is restricted to the 
closest pericellular space, the extracellular phosphatase is respon-
sible for the biomolecular phosphorylation in the extended ECM. 
We quantified both membrane bound and extracellular ALP in the 
SaOs2 and ATDC5 cell culture (performed under the same condi-
tions as previously described) in order to evaluate which one is 
crucial for the observed cytotoxicity. 
As expected, there is a distinct difference in the activity of the 
membrane bound ALP with ~15-20 times higher values for the 
SaOs2 compared to the ATDC5 cells (Figure 3C). Surprisingly, 
this drastic difference is not observed for the extracellular ALP. In 
this latter case, the SaOs2 cells also present a higher ALP activity, 
although, only by the factor of ~1.5-2.0. Moreover, the ALP activ-
ity is independent of the presence of 1 (Figure 3C). These results 
suggest that the dephosphorylation of 1 by the membrane bound 
ALP is the main responsible for the cytotoxicity of 1 towards the 
SaOs2 cells. 
The conversion of 1 to 2 by the SaOs2 cells in their close 
pericellular space was also confirmed by brightfield microscopy 
(Figure 4A,B). The images show a layer of gel covering the sur-
face of the cells cultured in the presence of 1. SEM was also used 
to analyze the SaOs2 cells under the same experimental condi-
tions. The SaOs2 cells exhibited a fibrous network in their 
pericellular space when 0.5 mM of 1 was used (Figure 4D), while 
these structures are absent in the control sample (i.e. 0 mM of 1, 
Figure 4C). The density of the fibrous network is increasing at 
higher concentration of 1 (Figure S11). 
 
Figure 4. (A,B) Brightfield and (C,D) SEM images of SaOs2 
cells, cultured during 7 h, in the (A, C) absence and (B, D) pres-
ence of 1 (0.5 mM). 
 These results are consistent with the recently reported nanonets 
of peptide amphiphiles, whose formation is triggered upon 
dephosphorylation of its derivative by surface and secretory phos-
phatases in the pericellular environment.18 As in the case of pep-
tides, the transformation of 1 to 2 by the membrane bound ALP 
leads to the formation of self-DVVHPEOHG ³FDJH-OLNH´ K\GURJHOV
around SaOs2 cells. These assemblies may reduce/block metabo-
lite exchange between the cells and thus, they have profound ef-
fect on critical cellular activities (e.g. adhesion, motility, prolif-
eration) that ultimately lead to cell apoptosis.36 
In summary, we demonstrated that a simple carbohydrate phos-
phate derivative (1) is converted into the self-assembling 
hydrogelator 2 in situ by the SaOs2 membrane-bound ALP. Upon 
conversion, 2 JHQHUDWHVDF\WRWR[LFQDQRQHWK\GURJHO³FDJH´VXr-
rounding the cells. We proved that this process is cell-specific, as 
other cell types, e.g. ATDC5, with lower membrane-bound ALP 
expression profiles are not affected by 1 at the same concentra-
tions as the ones tested for the SaOs2 cells. The reported system 
can be exploited in the development of anti-osteosarcoma strate-
gies. Our data can be further exploited in the design of similar 
systems sensitive to other types of enzymes that are overexpressed 
at the pericellular environment of other cancer cells and use them 
as therapeutic targets. Moreover, the larger diversity of the carbo-
hydrate regio- and stereochemistry, in comparison to the peptide-
based systems, opens additional possibilities for the design of 
amphiphiles with improved gelation and kinetics. 
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